$BCAX
Bicara Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BCAX down today? It is at $23.34 (-0.93%), and our scanner flagged it 38 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BCAX spikes, and full due diligence on BCAX — key stats, earnings, dilution and insider activity. Free.
Get free $BCAX alerts the moment volume spikes
Our scanner flagged $BCAX 38 times in the last 30 days. Create a free account to track $BCAX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $23.34
- Change today
- -0.93%
- Previous close
- $23.56
- 52-week range
- $10.29 – $30.99
- Market cap
- $1.53B
- Institutional own.
- 99.9%
- Total held
- 100.0%
- Short interest
- 10.5M ▲ +9% vs prior · as of 2026-08-14
- Days to cover
- 13.3d
- Avg daily volume
- 620K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.4x
- 15m
- 0.4x
- 1h
- 0.3x
- 1D
- 0.1x
Get free BCAX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $BCAX down today?
Here is the latest on BCAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMaterial Agreement, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders selling0 buys, 7 sells last 3 months (1/54 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cohlhepp Ryan Officer | Sold (automatic/other) | -19K 0.03% of company | sold 9.4% | 182K | $525K at $27.98 | Aug 10, 26 |
Cohlhepp Ryan Officer | Other | 19K 0.03% of company | added 10% | 200K | $71K at $3.79 | Aug 10, 26 |
Mazumdar Claire Officer | Sold (automatic/other) | -10K 0.02% of company | sold 2.7% | 362K | $280K at $27.98 | Aug 10, 26 |
Mazumdar Claire Officer | Other | 10K 0.02% of company | added 2.8% | 372K | $38K at $3.79 | Aug 10, 26 |
Hyep Ivan Officer | Sold (automatic/other) | -13K 0.02% of company | sold 8.8% | 130K | $350K at $27.97 | Aug 10, 26 |
Hyep Ivan Officer | Other | 13K 0.02% of company | added 9.6% | 142K | $47K at $3.79 | Aug 10, 26 |
Mazumdar Claire Officer | Sold (automatic/other) | -10K 0.02% of company | sold 2.7% | 362K | $284K at $28.42 | Jul 10, 26 |
Mazumdar Claire Officer | Other | 10K 0.02% of company | added 2.8% | 372K | $38K at $3.79 | Jul 10, 26 |
Cohlhepp Ryan Officer | Sold (automatic/other) | -536 | sold 0.3% | 182K | $16K at $29.00 | Jul 9, 26 |
Hyep Ivan Officer | Sold (automatic/other) | -28K 0.04% of company | sold 18% | 130K | $801K at $28.60 | Jul 8, 26 |
Hyep Ivan Officer | Other | 13K 0.02% of company | added 8.6% | 158K | $47K at $3.79 | Jul 8, 26 |
Cohlhepp Ryan Officer | Sold (automatic/other) | -28K 0.04% of company | sold 13% | 182K | $811K at $28.76 | Jul 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $BCAX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 9,375,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · Priced at $16/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$BCAX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$BCAX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to BCAX
Comparable names in pharmaceutical preparations, closest in size first.
BCAX stock FAQ
Why is $BCAX down today?
Here is the latest on BCAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the BCAX stock price today?
BCAX last traded at $23.34, down 0.93% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live BCAX alerts?
The BCAX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BCAX 38 times in the last 30 days.
What exchange is BCAX on?
BCAX (Bicara Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $1.53B in the PHARMACEUTICAL PREPARATIONS sector.
Is BCAX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BCAX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.